[go: up one dir, main page]

AR015917A1 - Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso - Google Patents

Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso

Info

Publication number
AR015917A1
AR015917A1 ARP980103146A ARP980103146A AR015917A1 AR 015917 A1 AR015917 A1 AR 015917A1 AR P980103146 A ARP980103146 A AR P980103146A AR P980103146 A ARP980103146 A AR P980103146A AR 015917 A1 AR015917 A1 AR 015917A1
Authority
AR
Argentina
Prior art keywords
solubility
sertralin
compositions
procedure
matter
Prior art date
Application number
ARP980103146A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR015917A1 publication Critical patent/AR015917A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP980103146A 1997-07-01 1998-06-29 Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso AR015917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
AR015917A1 true AR015917A1 (es) 2001-05-30

Family

ID=21971159

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP980103146A AR015917A1 (es) 1997-07-01 1998-06-29 Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso
ARP030102180A AR040280A2 (es) 1997-07-01 2003-06-19 Procedimiento para aumentar su solubilidad en un medio acuoso
ARP030102179A AR040279A2 (es) 1997-07-01 2003-06-19 Composiciones que contiene sal de sertralina

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP030102180A AR040280A2 (es) 1997-07-01 2003-06-19 Procedimiento para aumentar su solubilidad en un medio acuoso
ARP030102179A AR040279A2 (es) 1997-07-01 2003-06-19 Composiciones que contiene sal de sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (bg)
JP (1) JP2000514100A (bg)
KR (1) KR100366373B1 (bg)
CN (1) CN1261794A (bg)
AP (1) AP1192A (bg)
AR (3) AR015917A1 (bg)
AU (1) AU742535B2 (bg)
BG (1) BG103918A (bg)
BR (1) BR9810739A (bg)
CA (1) CA2290974C (bg)
CO (1) CO4940495A1 (bg)
DZ (1) DZ2548A1 (bg)
EA (1) EA002481B1 (bg)
HN (1) HN1998000102A (bg)
HR (1) HRP980377A2 (bg)
HU (1) HUP0002236A3 (bg)
ID (1) ID23429A (bg)
IL (1) IL133076A (bg)
IS (1) IS5260A (bg)
MA (1) MA24587A1 (bg)
NO (1) NO996520L (bg)
OA (1) OA11243A (bg)
PA (1) PA8454301A1 (bg)
PE (1) PE97199A1 (bg)
PL (1) PL337804A1 (bg)
SK (1) SK181099A3 (bg)
TN (1) TNSN98124A1 (bg)
TR (1) TR199903297T2 (bg)
TW (1) TW550087B (bg)
UA (1) UA67741C2 (bg)
UY (1) UY25071A1 (bg)
WO (1) WO1999001120A1 (bg)
YU (1) YU68299A (bg)
ZA (1) ZA985708B (bg)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2002002552A0 (en) 1999-12-23 2002-06-30 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations.
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
AU2001276608A1 (en) 2000-08-30 2002-03-13 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
CN102711762A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用固体医药组合物
TW201129557A (en) * 2009-12-29 2011-09-01 Kowa Co Pharmaceutical composition for oral administration
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) * 2022-05-20 2022-08-12 中化地质矿山总局地质研究院 一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (bg) 2000-07-31
CA2290974C (en) 2004-04-27
PL337804A1 (en) 2000-09-11
AP1192A (en) 2003-07-23
HRP980377A2 (en) 1999-04-30
IS5260A (is) 1999-11-19
BR9810739A (pt) 2000-09-12
EA199900962A1 (ru) 2000-08-28
TR199903297T2 (xx) 2000-07-21
NO996520D0 (no) 1999-12-28
HUP0002236A3 (en) 2003-12-29
AR040280A2 (es) 2005-03-23
TNSN98124A1 (fr) 2005-03-15
PE97199A1 (es) 1999-10-05
EA002481B1 (ru) 2002-06-27
NO996520L (no) 2000-02-29
SK181099A3 (en) 2000-07-11
JP2000514100A (ja) 2000-10-24
AU7544898A (en) 1999-01-25
UA67741C2 (uk) 2004-07-15
KR20010013365A (ko) 2001-02-26
ID23429A (id) 2000-04-20
YU68299A (sh) 2002-06-19
CN1261794A (zh) 2000-08-02
AR040279A2 (es) 2005-03-23
CA2290974A1 (en) 1999-01-14
KR100366373B1 (ko) 2003-01-14
WO1999001120A1 (en) 1999-01-14
MA24587A1 (fr) 1998-12-31
TW550087B (en) 2003-09-01
HUP0002236A2 (hu) 2003-08-28
UY25071A1 (es) 2000-12-29
ZA985708B (en) 2000-01-10
OA11243A (en) 2003-07-24
IL133076A (en) 2003-12-10
PA8454301A1 (es) 2000-09-29
DZ2548A1 (fr) 2003-02-08
IL133076A0 (en) 2001-03-19
AU742535B2 (en) 2002-01-03
EP0999829A1 (en) 2000-05-17
CO4940495A1 (es) 2000-07-24
AP9801280A0 (en) 1998-06-30
HN1998000102A (es) 1999-01-08

Similar Documents

Publication Publication Date Title
AR010579A1 (es) Composicion de limpieza y desinfeccion acuosa lista para usar y proceso para desinfeccion de superficies duras.
ES527150A0 (es) Un procedimiento para la preparacion de una solucion desinfectante acuosa de peroxido de hidrogeno.
MY122621A (en) Compositions containing a high percent saturation concentration of antibacterial agent
NO990160L (no) Anvendelse av en kombinasjon av surfaktanter, chelaterende midler og essensielle oljer for effektiv desinfeksjon
ATE312593T1 (de) Hautreinigungsmittel zur entfernung von tinte
BR9509720A (pt) Processo para a preparação de pequenas partículas compreendendo um composto orgânico cuja solubilidade é maior em um primerio solvente miscível em água que em um segundo solvente que é aquoso e uso das pequenas partículas
CO4750721A1 (es) Compuesto detergente para limpieza de inodoros, especialmente en bloques del tipo "dentro del tanque" o "bloque de borde
DK566686A (da) Rensning og/eller desinfektion af kontaktlinser
EA199900749A1 (ru) Фармацевтическая композиция
AR015917A1 (es) Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso
ES526823A0 (es) Procedimiento para la obtencion de agente de limpieza acuosos estables
ES2131704T3 (es) Limpieza y desinfeccion de lentes de contacto.
MX173001B (es) Composiciones detergentes liquidas para superficie dura que contienen agente tensioactivo detergente ionico de zwitter y monoetanolamina y/o beta-aminoalcanol
ES2051461T3 (es) Medios de contraste.
ES2073505T3 (es) Medios de contraste.
AR004315A1 (es) Composicion que comprende el producto precipitado en la mezcla de una sal metalica soluble y uno o mas compuestos que tienen un componente seleccionadode silicatos, fosfatos o boratos y metodo para el control de drenaje y/o retencion de agua en la formacion de una matriz de papel y para el tratamiento
KR930019808A (ko) 세정제 조성물
KR920014474A (ko) 담석 붕괴용 제제
ES2046422T3 (es) Composicion antimicrobiana y metodo de uso.
ES2082515T3 (es) Composiciones de aseo.
ES2168113T3 (es) Disolucion blanqueadora de lactona/peroxido, sistema blanqueador para formar la misma y metodo de preparacion y uso de la misma.
FR2803205B1 (fr) Solutions ioniques aqueuses et leurs utilisations notamment en ophtalmologie
AR020703A1 (es) Barra de limpieza de superficies duras.
JPS5320656A (en) Method of decoloring colored waste water
NZ332907A (en) Toilet cleansing block containing greater than 3% of a binder selected from cellulose binder or gum

Legal Events

Date Code Title Description
FC Refusal